Session
Medical, Chemical and Pharmaceutical Sciences
Description
Systemic erythematosus lupus is a chronic inflammatory disease of autoimmune nature. This illness can affect all organs, but one of the most common illnesses is lupus nephritis. Patients with renal impairment, despite aggressive immunosuppressive medication carry the risk of developing terminal renal disease and doing dialysis or renal transplant.The purpose of this study is to reflect global statistics on the frequency of the development of terminal renal disease in lupus nephritis patients as an awareness-raising way to stimulate studies that present a successful treatment or screening protocol in preventing this complication.This study is a review based on the research of world studies and literature regarding the prevalence of terminal renal disease in lupus nephritis patients.Over 50% of patients with LES, depending on different regions of the world, race / ethnicity develop lupus nephritis. 10-30% of lupus nephritis cases develop terminal renal disease where among the major risk factors are new age, nephrotic proteinuria, disease activity index, histological class of renal impairment, high creatinine, lack of remission, etc. Performing as early as possible the renal transplant increases the lifespan of patients with terminal renal disease.It is very difficult to prevent renal impairment in patients with LES, more so when some of them have lupus nephritis as the initial manifestation. However, since more than 50% of LES patients develop lupus nephritis and 10 to 30% of lupus nephritis cases develop terminal renal disease, studies should be encouraged to determine a successful treatment or screening protocol in preventing this complication.
Keywords:
systemic lupus erythematosus, prevalence, lupus nephritis, terminal renal disease
Session Chair
Besnik Elshani
Session Co-Chair
Petrit Biberaj
Proceedings Editor
Edmond Hajrizi
ISBN
978-9951-437-67-7
First Page
43
Last Page
47
Location
Durres, Albania
Start Date
28-10-2017 11:00 AM
End Date
28-10-2017 12:30 PM
DOI
10.33107/ubt-ic.2017.289
Recommended Citation
Duli, Marsida; Dika, Qamil; Duli, Xhenila; and Hankollari, Joana, "Prevalence of Terminal Renal Disease in Lupus Nephritis Patients" (2017). UBT International Conference. 289.
https://knowledgecenter.ubt-uni.net/conference/2017/all-events/289
Included in
Prevalence of Terminal Renal Disease in Lupus Nephritis Patients
Durres, Albania
Systemic erythematosus lupus is a chronic inflammatory disease of autoimmune nature. This illness can affect all organs, but one of the most common illnesses is lupus nephritis. Patients with renal impairment, despite aggressive immunosuppressive medication carry the risk of developing terminal renal disease and doing dialysis or renal transplant.The purpose of this study is to reflect global statistics on the frequency of the development of terminal renal disease in lupus nephritis patients as an awareness-raising way to stimulate studies that present a successful treatment or screening protocol in preventing this complication.This study is a review based on the research of world studies and literature regarding the prevalence of terminal renal disease in lupus nephritis patients.Over 50% of patients with LES, depending on different regions of the world, race / ethnicity develop lupus nephritis. 10-30% of lupus nephritis cases develop terminal renal disease where among the major risk factors are new age, nephrotic proteinuria, disease activity index, histological class of renal impairment, high creatinine, lack of remission, etc. Performing as early as possible the renal transplant increases the lifespan of patients with terminal renal disease.It is very difficult to prevent renal impairment in patients with LES, more so when some of them have lupus nephritis as the initial manifestation. However, since more than 50% of LES patients develop lupus nephritis and 10 to 30% of lupus nephritis cases develop terminal renal disease, studies should be encouraged to determine a successful treatment or screening protocol in preventing this complication.